Condition 1: Cervical Bishop Score. Condition 2: Duration of the latent phase of labor.
Conditions
Interventions
Intervention 1: Intervention group: 14 dexamethasone tablets with a dose of 0.5 mg for vaginal use, from Abu Reihan Pharmaceutical Company. Intervention 2: Control group: Plasbo tablets for 14 pieces
Sponsors
Alborz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Iranian Women Primigravid pregnancy Normal of Body Mass Index Single Pregnancy presentation cephalic in sonography Gestational age 38 weeks Bishop score 2 and less Normal Non Stress Test Estimate of Fetus Weight 2500-4000 gr Dont take hormonal, herbal and chemical drugs having a healthy water bag
Exclusion criteria
Exclusion criteria: Have Medicine And Midwifery Complication Lack of Desire for Cooperation Fetal Immobility and Maternal Bleeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical bishop score. Timepoint: Evaluation of cervical bishop score at the beginning of the study and 6 hours after vaginal use of dexamethasone tablets. Method of measurement: Vaginal examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of the latent phase of labor. Timepoint: From the time of entering the labor to a bishop score of 4 and above. Method of measurement: Vaginal Examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Torabi
Alborz University of Medical Sciences
Outcome results
None listed